Tue, Jul 29, 2014, 7:59 AM EDT - U.S. Markets open in 1 hr 31 mins

Recent

% | $
Click the to save as a favorite.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • yassen_gregorivich yassen_gregorivich Nov 8, 2012 4:21 PM Flag

    Obama's Bear market

    You may want to get out of 1/2 of all Bio-techs - or 1/2 of all stocks for that matter. I say 1/2 because seasonally this is usually when things tick up and bounce back strongly, but this appears to be the beginnings of a very long BEAR market that could be viciously brutal. Be very very careful.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I totally disagree, just look at the CELG announcement last nite. REGN has a pipeline that many companies envy, announcements could happen at any time.

      I don't doubt that there's still risk in the markets, so maybe more downside, but yesterday showed us how leveraged the biotechs are to the Nasdaq money.

      I may sell some puts, I see I can get $10 for the Dec REGN 145. If REGN gets put to me, I own it at 135...I see REGN as a $225 stock next yr, when this fog of political dysfunction clears.

      AEGR is a one trick pony, but I am hoping it's a good one trick pony!

      • 1 Reply to soflaturtle
      • Be careful as it is a very dicey market. Even when a stock gets approved like SRPT, it doubled on the news, then quickly gave it ALL back and then some. When a company gets the drug to market like VVUS, it DOUBLED then sales didn't materialize because of restrictions the government put on them and sales were pathetic. Vivus shocked down from more than $20 to the $10 it is at now. DNDN shot to $18 now it is down around $4. So even when they get approved, even when they get it to market, with the government constantly in the way, it ruins companies.

 
AEGR
30.07+0.07(+0.23%)Jul 28 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.